Pharmacy Pearls: GOLD Guideline UpdatesDecember 29th, 2023 | Asthma/COPD•Pharmacy Pearls
In this two-page edition of Pharmacy Pearls, you will find a review of the 2023 updates to the GOLD Guidelines for the treatment of COPD. There are several notable changes from previous versions of the guidelines, including a modification to the symptom/exacerbation risk assessment and the elimination of ICS+LABA as a routine treatment recommendation (other than if the patient is currently well-controlled on that regimen). There is also a review of all commercially available inhalers approved for COPD, including brand and generic names and typical dosing.
As always, we welcome any questions or feedback you may have. Just email the Pharmacy Team.